baber/WOPTO huggingface dataset:
Patent FI-973762-A0 (FI)
IPC: A61K38/00
Filed: 1997-09-23
Abstract: The present invention relates to a method for the diagnosis of a disease related to immune maturation and regulation of immune response towards self and nonself, comprising the steps of detecting in a biological specimen the presence of a DNA sequence comprising the sequence of SEQ ID NO:1.
Patent FI-974210-A0 (FI)
Inventor: LEE DOSUK D
IPC: A61F2/00
Filed: 1997-11-12
Abstract: The present invention provides a process for converting a standard inert amorphous calcium phosphate precipitate into highly reactive amorphous solids. The amorphous solids can be used to react with other calcium phosphate solids to form a poorly-crystalline synthetic hydroxyapatite that provides both bioactivity and structural integrity. This novel amorphous material can be reacted with other calcium phosphates at or below 37 °C to form a bone-like material consisting of poorly cyrstalline hydroxyapatite.
Patent FI-990414-A0 (FI)
Inventor: LAIHO KIMMO
IPC: G06F11/00
Filed: 1999-02-26
Abstract: A method is presented for preventing the unauthorized use of a certain protected interface (102) in a processor (101. 101'). An indication (NO PAT, ALARM) of attempted use of the protected interface is generated, and as a response to said indication, at least a major part of the operation of the processor is disabled (DISABLE).
Patent IL-64332-A0 (IL)
Title: Compounds of dichlorodiethylamino-phenylalanine with anti-cancer tumor activity
IPC: C07C231/00
Filed: 1981-11-22
Abstract: Compound with high anti-tumour activity and of moderate toxicity are described which are constituted by tripeptides formed from dichlorodiethylaminophenylalanine, para-fluorophenylalanine and methionine bonded together by peptide links. 
<??>The tripeptides of the invention are particularly useful in the treatment of malignant tumours.
Patent IL-67746-A0 (IL)
Title: 2-piperazinyl-4-phenyl quinazoline derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D239/78
Filed: 1983-01-24
Abstract: The present invention relates to new derivatives of formula: <IMAGE>  (II)  in which: R3 denotes a halogen, preferably chlorine, or a nitro group, R4 represents hydrogen or a lower alkyl group having from 1 to 4 atoms of carbon, R5 represents an atom of halogen, preferably chlorine or fluorine. It also relates to a process for preparing products of formula (II) and to the drugs containing at least one product of formula (II).
Patent IL-74287-A0 (IL)
Title: Serial flow continuous separation process
IPC: B01D53/04
Filed: 1985-02-08
Abstract: A process for separating an extract component from a raffinate component contained in a feed mixture. A unidirectional fluid flow system is maintained through a series of separating units through which the components travel at different rates. The units are interconnected in series so as to form a single closed loop. A component concentration distribution is established within the system of units so as to comprise a series of zones. Feed and displacement fluid are each mixed with a different intercolumn stream prior to being passed into the inlets of two of the units and extract and raffinate are taken only as portions of streams from outlets of two or more of the units at appropriate points on the component concentration distribution. At the appropriate times the inlets and outlets are shifted so as to simulate movement of the units in a direction downstream with respect to the direction of fluid flow and thereby enable the inlets and outlets to continually lie in the appropriate zones.
Patent IL-84856-A0 (IL)
Title: Azolyl derivatives,their preparation and their use as fungicides
IPC: C07D249/08
Filed: 1987-12-17
Abstract: There are described compounds having general formula: <CHEM>  wherein: R<1> is selected from the group comprising F, Cl, Br, CF3, a phenyl, a C1-C2 alkoxy, a C1-C2 haloalkoxy, an alkylthio, a haloalkylthio radical, in which the halogen is F, Cl, Br;  R<2> is selected from the group comprising H, F, Cl, Br, CF3;  R<3> is H, a C1-C4 alkyl or a C3-C6 cycloalkyl radical;  Y is selected from the group comprising H, CH3, OH, CN, F;  n is 2, 3, 4 or 1 as well, when Y is OH;  m is 0 or 1;  X is O or S; Rf is selected from the group consisting of C1-C5 polyfluoroalkyl, C2-C4 polyfluoroalkenyl, polyfluoroalkoxyalkyl and polyfluoroalkoxyalkenyl radicals, each of them containing at least two fluorine atoms and, optionally, other halogen atoms selected from Cl and Br; Z is CH or N. m
Patent IL-84983-A0 (IL)
Title: Guanidinoacetic and ethanamidinoacetic acid derivatives as sweetening agents and sweetening compositions containing the same
IPC: A61K8/44
Filed: 1987-12-29
Abstract: Sweetening agents of the formula: <IMAGE> in which, in a preferred embodiment, R0 is: either a heterocyclic ring constructed on a cyclopentadienyl or phenyl group by replacement of 1 to 3 cyclic C with N, O or S, or an indanyl, indenyl, naphthyl or tetrahydronaphthyl group or a heterocyclic derivative constructed on these groups by replacement of 1 to 4 cyclic C with N, O or S; R1 is H or CH3; R2 is a 2-13 C hydrocarbon group in which up to 4 C may be replaced by N, O, S, Cl, Br and I and up to 5 H by F; R3 and R4 are H.
Patent IL-87682-A0 (IL)
Title: Method and test system for determining hemoglobin derivatives in blood
IPC: G01N33/66
Filed: 1988-09-06
Abstract: An analytical method for determining the relative amount of a particular hemoglobin derivative, e.g., glycated hemoglobin, in a blood sample wherein the amounts of both total hemoglobin and the hemoglobin derivative are measured and related mathematically, e.g., as a percentage. The blood sample is treated with the combination of a thiocyanate salt and an oxidant to denature the hemoglobin in the sample and to convert hemoglobin to met-hemoglobin. Met-hemoglobin is measured spectrophotometrically to give the amount of total hemoglobin present, and the denatured hemoglobin derivative can be distinguished and measured by immunoassay. The presence of the oxidant in the denaturant solution has been found to increase the rate of denaturation of hemoglobin thereby reducing the overall assay time and improving the reliability of the determination.
Patent IL-91646-A0 (IL)
Title: Polyurethanes active in non-linear optics and their production and applications
IPC: C08G18/32
Filed: 1989-09-14
Abstract: The invention relates to a polyurethane which permits the preparation of optically active non-linear materials. This polyurethane is characterised in that it has a recurring unit of the formula <IMAGE> in which m is a number greater than 5, R1 and R2, which are identical or different, represent a saturated or unsaturated alkyl radical or an aromatic radical and R3 represents a linear or cyclic aliphatic hydrocarbon radical or an aromatic or arylaliphatic radical, and Y represents a group comprising a radical with delocalised  pi electrons and an electron acceptor group (A).
Patent IL-94077-A0 (IL)
Title: Lipopolyamines,their preparation and application
IPC: C07C229/00
Filed: 1990-04-12
Abstract: Intermediate compounds useful for producing transfecting lipopolyamines, comprising:    <IMAGE>   wherein m is an integer between 2 and 6 inclusive, wherein n is an integer between 2 and 5 inclusive, wherein R5 represents a hydrogen atom or a carboxyl radical but no more than one R5 represents a carboxyl, the values of m in the different fragments (CH)m may be identical or different, and wherein the symbol Z R5 represent a group protecting the amine function.
Patent SE-8804457-A0 (SE)
Title: Förfarande för rotationsborrning och rotationsborrningsanordning
Inventor: SALMI PEKKA
IPC: E21B19/086
Filed: 1988-12-09
Abstract: o uppfinningen avser ett fOrfarande fOr rotationsborrning, vid vilket ett rotationshuvud framfores mot ett foremal som skall borras och vid vilket ett i rotationshuvudet inkluderat och med borrorgan forbundet nackelement (3) roteras king sin longitudinella axel relativt en rotationshuvudkropp (1). Vid f8rfarandet utsdtts nackelementet (3) i en normal borrningssituation genom fOrmedling av.rotationshuvudkroppen (1) f8r verkan av tva motsatt riktade, medelst ett tryckmedium alstrade krafter (Fl F2), varvid den fOrsta (F1) verkar I borrningsriktningen och den andra (F2) i riktningen motsatt borrningsriktningen, varvid den farsta kraften (F1) är storre och skillnaden mellan krafterna alstrar en frammatningskraft (Fs). Nackelementet (3) dr forsett med en mojlighet att rbra sig i den faktiska riktningen av frammatningskraften, varigenom i en borrningssituation, om en pa nackelementet (3) utovad och i motsatt riktning mot frammatningskraften verkande kraft (FM) dr kraftfullare an frammatningskraften (Fs), nackelementet (3) ror sig i riktningen motsatt borrningsriktningen relativt rotationshuvudkroppen (1). Under ndmnda rorelse halls den forsta kraften (FI) atminstone like med vad som kravs i en normal situation och den andra kraftens (F2) verkan elimineras. Mar den pa. nackelementet (3), utOvade och motsatt frammatningskraften (Fs) riktade kraften (FM) farsvagas, aterinsatts verkan fran namnda forsta (FI) och andra (F2) krafter, och saledes den ddrigeom alstrade frammatningskrafen (Fs), med nackelementet (3) rarande sig i borrningsriktningen. Uppfinningen avser Liven en rotationsborrningsanordning ftir utfarande av fOrfarandet. (Fig 3) :%••„. a) ?) F193 Fs ?. F ••• ••• • • ••••I,•• • "elf(••• •• 'le •• ••• • • ••• • 11 • • a• •• :■•••• /toe,. ••••4 t• aa • it 2L1 L_ Iry 3532 33b 3 1 29 9 30 aSkw , • \`111FAI waszvki 2521 23/8 27 3 ri 9 62 6 22 SIfig IferAVI Ading11111111.11■ MINIENSinarr litialliar alta- ,330 2 8
Patent AU-PO726897-A0 (AU)
Title: Method for assessing a predisposition to bipolar affective disorder
IPC: C12Q1/68
Filed: 1997-06-10
Abstract: A method of assessing an individual's predisposition to bipolar affective disorder comprises determining the presence of one or more bipolar affective disorder-linked markers on chromosome 4 or analyzing allelic variation in relation to a bipolar affective disorder susceptibility gene on chromosome 4.
Patent FI-20050213-A0 (FI)
Inventor: TAMMELA SIMO
IPC: H01S3/094
Filed: 2005-02-23
Abstract: The invention relates to a bundle for fiber lasers, wherein two optical fibers (10, 14) attached to each other exclusively by a removable bridging element (11) along a section of their length, the two optical fibers being freed from each other in at least another section of their length. The bridging element comprising silica glass, which has a refractive index essentially the same to that of a material of an outer layer of the two optical fibers, and the bridging element is a sacrificial layer (19) deposited on only one of the two optical fibers, a material of the sacrificial layer being doped so as to increase a wet etching speed of the sacrificial layer as compared to a material of the two optical fibers in order to be more easily removable.
Patent IL-109793-A0 (IL)
Title: Preparation of cyclopropane esters
IPC: C07C69/747
Filed: 1994-05-25
Abstract: A process for the preparation of a lower alkyl ester of 3-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)- 2,2-dimethylcyclopropane carboxylic acid where lower alkyl means alkyl of up to four carbon atoms which comprises the steps of (a) reacting a compound of formula: CF3-CXCl-CH(OH)-CH=C(CH3)2 wherein X is chloro or bromo, with a tri-lower-alkyl orthoacetate containing up to four carbon atoms in each alkyl group in the presence of at least a catalytic amount of an active clay at an elevated temperature for a sufficient time to obtain a compound of formula: CF3-CXCl-CH=CH-C(CH3)2-CH2CO2R wherein R is an alkyl group containing up to four carbon atoms, and (b) treating said compound of formula (III) with at least one molar equivalent of a base to obtain said alkyl ester of 3-(2-chloro-3,3,3-trifluoroprop-1-en-1-yl)-2,2-dimethylcyclopropane carboxylic acid.
Patent IL-110894-A0 (IL)
Title: Cephem derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
IPC: C07D501/59
Filed: 1994-09-08
Abstract: New cephem compounds of formula (I), wherein R<1> is amino or protected amino, R<2> is hydrogen, lower alkyl or hydroxy protective group, R<3> is carboxy or protected carboxy, R<4> is 3-pyridyl, 4-pyridyl or optionally substituted heteromonocyclic group containing two nitrogen atoms as hetero atoms, and which may also contain one oxygen or sulfur atom, and n is 0, 1 or 2, provided that when R<2> is lower alkyl, then n is 1 or 2 and R<4> is optionally substituted heteromonocyclic group containing two nitrogen atoms as hetero atoms, and which may also contain one oxygen or sulfur atom, and pharmaceutically acceptable salts thereof which are useful as a medicament.
Patent IL-111241-A0 (IL)
Title: Closure for high voltage cable connections
IPC: H02G15/103
Filed: 1994-10-11
Abstract: A closure is provided for connections between high voltage cables and other electrical equipment, such as another high voltage cable, a transformer, or switch gear. Insulation is provided by an insulating gel which forms interfaces with itself and/or materials of the cable or other electrical equipment. The interfaces have a high interfacial dielectric strength, which prevents failure along the interfaces.
Patent IL-127806-A0 (IL)
Title: Composition for altering hair growth and hair pigmentation
IPC: A61Q5/00
Filed: 1997-06-25
Abstract: The present invention utilizes serine proteases and their ability to induce programmed cell death and apoptosis in the follicular papillae to affect changes in mammalian hair growth and hair pigmentation. Also described are compositions which have an agent with a portion of similar structure to a portion of the trypsin molecule, allowing said agent to induce programmed cell death and apoptosis in the same manner as trypsin.
Patent IL-144558-A0 (IL)
Title: Methods for identifying, treating of monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
IPC: A61P19/10
Filed: 2000-01-25
Abstract: The invention provides devices, kits and methods for delivering an agent to a breast milk duct. Intraductal agent delivery provides an opportunity to treat a breast condition locally and avoid the pitfalls of systemic drug delivery for a local condition. Time-released agents delivered into the ducts using an intraductal device or formulation reduces the frequency of intraductal administration required for desired efficacy over time. The methods include methods of treating a breast condition, including the conditions of cancer or precancer.
Patent IL-146438-A0 (IL)
Title: Process and product for enhancing immune response in companion animal using a combination of antioxidants
IPC: A61K31/047
Filed: 2000-05-26
Abstract: A process for feeding a companion animal such as a dog a diet containing an effective amount of a combination of antioxidants to enhance immune response and improve the overall health of the animal is provided. Preferably, the diet includes from about 175 to about 400 IU of vitamin E per kilogram of diet, from about 1 to about 50 mg/day of lutein, and from about 1 to about 50 mg/day of beta-carotene.
Patent IL-147105-A0 (IL)
Title: Method for data care in a network of partially replicated database systems
IPC: G06F12/00
Filed: 2000-05-13
Abstract: Methods and systems for data maintenance in an offline-distributed database network system, which comprises a central system having a central database, and node systems having local databases capable of containing different subsets of data from the central database. First, change information relating to data stored in at least one of the central and local databases is recorded in at least one of the node systems. Then, a replication object including the change information is transmitted, if an online connection is available, from the recording node systems to the central system or from the central system to the recording node systems. The recipients of the replication object are determined based on at least one lookup table in the central system. The lookup table is updated in accordance with the change information of the replication object.
Patent IL-150149-A0 (IL)
Title: A specialized memory device
IPC: G06F15/78
Filed: 2002-06-11
Abstract: A specialized memory chip which includes an embedded application specific signal processing unit ASSPU. The ASSPU handles one or more predetermined tasks instead of a main processing unit. The ASSPU and the main processing unit can access memory on the memory chip simultaneously.
Patent IL-162783-A0 (IL)
Title: In-bound call directed telephone station and method of directing a telephone station based on an in-bound call
IPC: H04M1/57
Filed: 2003-01-03
Abstract: An in-bound call directed telephone station, and a method, which may be embodied in a computer readable medium, directs a telephone station based on an in-bound call. The inbound directed telephone station includes means for providing a handset having a call receiver and a call originator, means for providing a first memory location, coupled to the call receiver, and means for providing a comparator coupled to the first memory location and to the call receiver. Upon receipt of an inbound call by the call receiver and before the call receiver answers the in-bound call, the comparator compares an identifier of the in-bound call to an identifier list in the first memory location and terminates receipt of the in-bound call by the call receiver. Upon locating a match between the identifier list and the identifier of the in-bound call, the comparator automatically activates the call originator to perform a function associated with the in-bound call identifier. The method includes receiving a call at the telephone, activating an identification system based on the receiving, which identification system identifies an origination of an in-bound communication, associating a function with the in-bound communication based on the origination, terminating the in-bound communication after the activating of the identification system and before answering the in-bound call, and automatically performing, by the telephone, of the function associated with the in-bound communication.
Patent IL-172548-A0 (IL)
Title: Emitter-binding peptides causing a change in the spectral emission properties of the emitter
IPC: C07K16/44
Filed: 2005-12-13
Abstract: This invention relates to emitter-binding peptides that produce a change in the spectral emission properties of the emitter in the case of an interaction of its antigen-binding pocket with the emitter. The emitter-binding peptides of the invention are in particular components of antibodies and antibody fragments.
Patent IL-177240-A0 (IL)
Title: Scalable bus structure
IPC: G06F13/40
Filed: 2006-08-02
Abstract: A processing system is disclosed with a sending component and a receiving component connected by a bus. The bus may be configured with first and second channels. The sending component may be configured to broadcast on the first channel read and write address information, read and write control signals, and write data. The sending component may also be configured to signal the receiving component such that the receiving component can distinguish between the read and write address information, the read and write control signals, and the write data broadcast on the first channel. The receiving component may be configured to store the write data broadcast on the first channel based on the write address information and the write control signals, retrieve read data based on the read address information and the read control signals, and broadcast the retrieved read data on the second channel.
Patent IL-182063-A0 (IL)
Title: Methods and compositions for evaluating breast cancer prognosis
IPC: G16B20/00
Filed: 2007-03-20
Abstract: Methods and computer program products for evaluating and optimizing one or more markers for use in establishing a prognosis for a patient suffering from a disease are provided. More particularly, the methods include steps for systematically evaluating a number of features that may be extracted from an image of a body sample, such as a histological slide, that has been exposed to one or more biomarkers so as to establish a prognostic decision rule based on one or more of the extracted features such that the decision rule yields a prognosis that is optimally predictive of actual patient outcome. Thus, the methods and computer program products provided yield optimally predictive prognoses to assist clinicians in developing strategies for effective patient care management.
Patent IL-182831-A0 (IL)
Title: Method for the production of phthalic dichloride
Filed: 2007-04-26
Abstract: A process for preparing phthaloyl chloride by reacting phthalic anhydride with a chlorinating agent (I) selected from the group of thionyl chloride and phosgene in the presence of a catalyst at a temperature of from 80 to 200° C. and a pressure of from 0.01 to 10 MPa abs, in which the catalyst (II) used is triphenylphosphine, triphenylphosphine oxide or a mixture thereof.
Patent IL-190862-A0 (IL)
Title: Transmitter architectures for communications systems
IPC: H04B1/04
Filed: 2008-04-14
Abstract: Transmitter architectures for a communications system having improved performance over conventional transmitter architectures. The improvements include a combination of the following: faster response time for the control signals, improved linearity, reduced interference, reduced power consumption, lower circuit complexity, and lower costs. For a cellular application, these improvements can lead to increased system capacity, smaller telephone size, increased talk and standby times, and greater acceptance of the product. Circuitry is provided to speed up the response time of a control signal. The control loop for various elements in the transmit signal path are integrated. A gain control mechanism allows for accurate adjustment of the output transmit power level. Control mechanisms are provided to power down the power amplifier, or th e entire transmit signal path, when not needed. The gains of the various elements in the transmit signal path are controlled to reduce transients in the output transmit power, and to also ensure that transients are downward.
Patent IL-199773-A0 (IL)
Title: Method for cloning cognate antibodies
Filed: 2009-07-09
Abstract: The invention relates to a procedure for linking cognate pairs of VH and VL encoding sequences from a population of cells enriched in particular surface antigen markers. The linking procedure involves a multiplex molecular amplification procedure capable of linking nucleotide sequences of interest in connection with the amplification, in particular polymerase chain reaction (multiplex PCR). The method is particularly advantageous for the generation of cognate pair libraries as well as combinatorial libraries of variable region encoding sequences from immunoglobulins. The invention also relates to methods for generation of chimeric human/non-human antibodies and expression libraries generated by such methods.
Patent IL-217961-A0 (IL)
Title: Hinge for cold rooms, swing gates or the like
Filed: 2012-02-06
Abstract: A hinge for cold rooms, swing gates or the like, which comprise a stationary support structure  (S)  and at least a door  (A)  movable between an open door position and a closed door position. The hinge comprises a box-like hinge body  (3)  and a pin  (5)  reciprocally rotatably coupled to rotate about a first axis  (X)  between the open door position and the closed door position. Closing means are provided  (10)  for automatically returning the door  (A),  as well as a working fluid acting thereon to hydraulically contrast their action. The closing means  (10)  comprise a cam element  (11)  unitary with said pin  (5)  interacting with a plunger element  (12)  housed in an operating chamber  (25)  defined within the box-like hinge body  (3).  The box-like hinge body  (3)  has an elongated shape to define a second axis  (Y)  perpendicular to the first one  (X).